Literature DB >> 17363399

Development of active tuberculosis following initiation of infliximab despite appropriate prophylaxis.

S Raychaudhuri, R Shmerling, J Ermann, S Helfgott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17363399      PMCID： PMC2666304          DOI： 10.1093/rheumatology/kel447

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid.

Authors:  Jorge Parra Ruiz; Norberto Ortego Centeno; Enrique Raya Alvarez
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

2.  The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial.

Authors:  Rene Westhovens; David Yocum; John Han; Alberto Berman; Ingrid Strusberg; Piet Geusens; Mahboob U Rahman
Journal:  Arthritis Rheum       Date:  2006-04

3.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

4.  Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Authors:  Loreto Carmona; Juan J Gómez-Reino; Vicente Rodríguez-Valverde; Dolores Montero; Eliseo Pascual-Gómez; Emilio Martin Mola; Luis Carreño; Manuel Figueroa
Journal:  Arthritis Rheum       Date:  2005-06

Review 5.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  TNF-blocking agents and tuberculosis: new drugs illuminate an old topic.

Authors:  J Keane
Journal:  Rheumatology (Oxford)       Date:  2005-03-01       Impact factor: 7.580

7.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.

Authors:  G W Comstock; C Baum; D E Snider
Journal:  Am Rev Respir Dis       Date:  1979-05

Review 8.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  S Woldehanna; J Volmink
Journal:  Cochrane Database Syst Rev       Date:  2004
  8 in total
  2 in total

1.  Infliximab in the treatment of plaque type psoriasis.

Authors:  Rosita Saraceno; Andrea Saggini; Lucia Pietroleonardo; Sergio Chimenti
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-03

2.  Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment.

Authors:  Kozo Ikuta; Yumiko Ota; Shigenobu Kuroki; Yoshihide Matsumoto; Eri Senda; Saki Mukohara; Soshi Takahashi; Kazuya Monden; Akihisa Fukuda; Hiroshi Seno; Shunichi Kumagai; Seiji Shio
Journal:  Intern Med       Date:  2019-11-22       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.